Mettler-Toledo International Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Mettler-Toledo International Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $206.25M, a 5.71% decline year-over-year.
- Mettler-Toledo International Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $206.25M, a 5.71% decline year-over-year.
- Mettler-Toledo International Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $143.75M, a 32.35% decline year-over-year.
- Mettler-Toledo International Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $218.75M, a 2.94% increase year-over-year.
- Mettler-Toledo International Inc. payments for repurchase of common stock for fiscal 2025 was $800.00M, a 5.88% decline from fiscal 2024.
- Mettler-Toledo International Inc. payments for repurchase of common stock for fiscal 2024 was $850.00M, a 5.56% decline from fiscal 2023.
- Mettler-Toledo International Inc. payments for repurchase of common stock for fiscal 2023 was $900.00M, a 18.18% decline from fiscal 2022.
- Mettler-Toledo International Inc. payments for repurchase of common stock for fiscal 2022 was $1.10B, a 10.00% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $206.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $775.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $206.25M 10-Q · filed 2026-05-08 | $787.50M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $143.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $800.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | $218.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $868.75M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $218.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $862.50M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $218.75M 10-Q · filed 2026-05-08 | $856.25M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $212.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $850.00M 10-K · filed 2026-02-06 |
| 2024-09-30 | $212.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $813.50M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $212.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $825.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $212.50M 10-Q · filed 2025-05-02 | $862.50M derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | $176.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $900.00M 10-K · filed 2026-02-06 |
| 2023-09-30 | $224.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $999.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $250.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.05B derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $250.00M 10-Q · filed 2024-05-10 | $1.07B derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $275.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $1.10B 10-K · filed 2025-02-07 |
| 2022-09-30 | $275.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.10B derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $275.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $1.07B derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $275.00M 10-Q · filed 2023-05-05 | $1.01B derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $272.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1000.00M 10-K · filed 2024-02-09 |
| 2021-09-30 | $252.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.10B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $212.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $1.05B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $262.50M 10-Q · filed 2022-05-06 | $837.50M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $375.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $775.00M 10-K · filed 2023-02-10 |
| 2020-09-30 | $200.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $616.25M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $602.50M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $200.00M 10-Q · filed 2021-05-07 | $788.75M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $216.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $775.00M 10-K · filed 2022-02-11 |
| 2019-09-30 | $186.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $677.50M derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-06-30 | $186.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $610.00M derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-03-31 | $186.25M 10-Q · filed 2020-05-08 | $542.50M derived: sum of 4 quarters · filed 2021-02-08 |
| 2018-12-31 | $118.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $475.00M 10-K · filed 2021-02-08 |
| 2018-09-30 | $118.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $421.25M derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-06-30 | $118.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $387.55M derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-03-31 | $118.75M 10-Q · filed 2019-05-10 | $393.75M derived: sum of 4 quarters · filed 2020-02-07 |
| 2017-12-31 | $65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $400.00M 10-K · filed 2020-02-07 |
| 2017-09-30 | $85.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $460.00M derived: sum of 4 quarters · filed 2019-02-08 |
| 2017-06-30 | $124.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $499.94M derived: sum of 4 quarters · filed 2019-02-08 |
| 2017-03-31 | $125.00M 10-Q · filed 2018-05-04 | $499.99M derived: sum of 4 quarters · filed 2019-02-08 |
| 2016-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $499.99M 10-K · filed 2019-02-08 |
| 2016-09-30 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $498.74M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-06-30 | $125.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $497.49M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-03-31 | $125.00M 10-Q · filed 2017-05-05 | $496.22M derived: sum of 4 quarters · filed 2018-02-09 |
| 2015-12-31 | $123.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-09 | $494.97M 10-K · filed 2018-02-09 |
| 2015-09-30 | $123.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $488.75M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-06-30 | $123.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $477.50M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-03-31 | $123.75M 10-Q · filed 2016-05-06 | $455.25M derived: sum of 4 quarters · filed 2017-02-02 |
| 2014-12-31 | $117.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $414.00M 10-K · filed 2017-02-02 |
| 2014-09-30 | $112.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $374.04M derived: sum of 4 quarters · filed 2016-02-04 |
| 2014-06-30 | $101.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $334.11M derived: sum of 4 quarters · filed 2016-02-04 |
| 2014-03-31 | $82.50M 10-Q · filed 2015-05-08 | $305.17M derived: sum of 4 quarters · filed 2016-02-04 |
| 2013-12-31 | $77.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-04 | $294.98M 10-K · filed 2016-02-04 |
| 2013-09-30 | $72.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $288.24M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-06-30 | $72.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $287.75M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-03-31 | $72.30M 10-Q · filed 2014-05-09 | $287.25M derived: sum of 4 quarters · filed 2015-02-06 |
| 2012-12-31 | $70.82M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $278.67M 10-K · filed 2015-02-06 |
| 2012-09-30 | $72.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $241.25M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | $72.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $226.16M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | $63.72M 10-Q · filed 2013-05-03 | $211.12M derived: sum of 4 quarters · filed 2014-02-07 |
| 2011-12-31 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $204.58M 10-K · filed 2014-02-07 |
| 2011-09-30 | $57.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $262.38M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | $57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $281.38M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-03-31 | $57.18M 10-Q · filed 2012-05-04 | $268.00M derived: sum of 4 quarters · filed 2013-02-08 |
| 2010-12-31 | $91.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $240.00M 10-K · filed 2013-02-08 |
| 2010-09-30 | $76.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | |
| 2010-06-30 | $43.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | |
| 2010-03-31 | $29.18M 10-Q · filed 2011-05-05 | |
| 2009-12-31 | $5.99M 10-K · filed 2012-02-13 | |
| 2008-12-31 | $229.67M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |